Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States

Basic Details
Date
Tuesday, August 21, 2018
Type
Presentation
Medical Product
alemtuzumab
daclizumab
dalfampridine
dimethyl fumarate
fingolimod
glatiramer acetate
interferon beta-1A
interferon beta-1B
mitoxantrone
natalizumab
peginterferon beta-1a
teriflunomide
Presenter(s)

Danijela Stojanovic, Mayura Shinde, Nicole Haug, Mohamed Mohamoud, Leyla Sahin, Genna Panucci, Rajani Rajbhandari, Lockwood Taylor